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Abstract 
Carbon-based nanomaterials represent a new tool in future medical applications. Thus, 
focusing on the evaluation of the degree of their safety has been growing in the last years. In 
this study we were particularly interested in understanding the impact of few layer graphene 
(FLG) on primary murine lymphocytes. These B and T cells, that are the second, but 
specialized, line of defense of the immune system, rely on various mechanisms to ensure their 
efficient function and maintenance. One of these mechanisms is autophagy that can be 
triggered by various nanomaterials in some types of cells. For these reasons, we were 
interested to evaluate the way FLG could affect this process in lymphocytes. Our results point 
out that FLG does neither impact the viability and activation of T and B cells, nor their 
autophagic activity. Using confocal microscopy, we were also able to see that FLG does not 
appear to cause any membrane damages and that does not penetrate inside of these cells. 
Overall, our data do not show any impact of this material on lymphocyte homeostasis, which 
is one more argument in favor of the continuation of studies investigating the potential of 
FLG for therapeutic applications. 
 
1. Introduction 
Graphene-based materials (GBMs) such as graphene or few layer graphene (FLG) harbor 
a myriad of properties that make them suitable for various tasks ranging from electronics, 
photonics to biomedical applications.
1,2
 These 2-dimensional sheets, organized in a honey-
comb like structure, are excellent charge carriers with a high mechanical strength. They  can 
be used for reinforcing composites and as efficient sensors.
3–5
 These properties make also 
graphene a promising and valuable candidate in nanomedicine with a high potential in 
diagnosis and in therapy.
6,7
 Indeed, graphene with its elasticity and strength, could be on one 
hand an excellent alternative to existing metallic or silicone implants, but also a unique 
material to design biosensors, drug and/or gene delivery systems.
8
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To explore the potential of FLG, especially in a biomedical context, it is of high 
importance to first investigate the risk to induce cytotoxic effects and/or to disturb specific 
intracellular processes. Evaluating the safety of nanomateriale (NMs) is indeed one of the 
major concerns in the nano-field.
2
  The first step towards this goal is to start the inquiry at the 
cellular level. The interactions of GBMs with cells, as mostly demonstrated with graphene 
oxide (GO), the oxidized form of graphene, have been shown to be highly dependent on the 
cell type but also to trigger various mechanisms potentially leading to cell death.
9,10
 One 
recurrent observation, in cells interacting with GBMs, is the production of significant amounts 
of reactive oxygen species (ROS) leading thus to oxidative stress.
2,6,9
 Another mechanism that 
has been associated to these materials is macroautophagy. This process, aimed to maintain 
cellular homeostasis, can also be activated by stress signals, such as ROS. Macroautophagy is 
a lysosomal degradation pathway mainly targeting cytoplasmic content such as aggregated 
proteins and damaged organelles. It is characterized by a multi-step process leading to the 
formation of double membrane vesicles called autophagosomes. Their subsequent fusion with 
lysosomes completes the process and results in the breakdown and turnover of the captured 
material.
10
 Macroautophagy, more commonly referred to as autophagy, is not solely a pro-
survival mechanism but has paradoxically also been associated to apoptosis in cases of either 
the blockade or an overactivation  of the process.
11
 Some NM have indeed been reported to be 
able to modulate autophagy in various ways.
12
 GO for instance appears to increase autophagy 
in macrophages, while carbon nanotubes induce a blockade of the autophagic flux as 
demonstrated in human umbilical vein endothelial cells and in macrophages.
13–15
 Autophagy 
is also tightly linked to immune responses such as inflammatory responses, antigen 
presentation,  pathogen clearance or lymphocyte homeostasis.
16
 Since the immune system 
represents the first line of defense against any foreign element, we were interested in 
exploring the possible influence of FLG on autophagic functions of primary immune cells and 
in particular murine lymphocytes. 
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Only few and quite recent studies have been focused on understanding the impact of 
graphene or FLG on mammalian cells, and most of them were investigating the impact of 
graphene on cell lines with the exception of a study by Russier et al. that showed that FLG 
was able to selectively kill pathogenic monocytes from myelomonocytic leukemia patients.
17–
19
 However, to the best of our knowledge, no study has been looking into the impact of FLG 
on primary lymphocytes and on their autophagic activity. As these cells are key players in 
adaptive immunity, it appears essential to understand how FLG could interact with them. 
 
2. Materials and methods 
2.1. Graphene preparation and characterization 
Few-layer graphene (FLG) was prepared by ball-milling treatment, according to previous 
published procedures.
20,21
 In general, a mixture of graphite and melamine (1,3,5-Triazine-
2,4,6-triamine) (7.5 mg of SP-1 graphite powder, purchased from Bay Carbon, Inc., and 22.5 
mg of melamine purchased from Sigma-Aldrich) was ball milled at 100 rpm for 30 min using 
a Retsch PM 100 planetary mill under air. The resulting solid mixture was dispersed in 20 mL 
of water and sonicated for 1 min to produce a dark suspension. Melamine is afterwards 
eliminated by dialysis. Some precipitate, consisting in poorly exfoliated graphene, was 
removed from the liquid fraction after stabilization for 5 days. The final FLG water 
dispersions were lyophilized and the final graphene powder was thoroughly characterized. 
Quantitative elemental analysis on FLG was performed with a LECO CHNS-932 elemental 
analyzer. FLG was also studied by TEM. A stable dispersions of the nanomaterial was drop-
cast on a nickel grid (3.00 mm, 200 mesh) and dried under vacuum. The sample was studied 
by high-resolution transmission electron microscopy (HRTEM) JEOL 2100 at an accelerating 
voltage of 200 kV. Lateral dimension distribution was calculated by using Fiji-win64 
software. In addition, the dispersion of FLG was drop-cast onto a Si wafer and dried on a hot 
plate in order to study the Raman spectrum. At least 20 Raman measurements were collected 
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in different locations using a Renishaw inVia Reflex Microscope at 532 nm with a 100× 
objective and an incident power of 1% (1 mWµm
-2
). 
2.2. Dispersibility study 
FLG was resuspended in culture medium RPMI 1640 (Lonza BioWhittaker, Levallois, 
France) supplemented with 10% FBS at a working concentration of 100 mg mL
-1
  in a 
homemade chambered coverglass. Fluorescein sodium salt (Fluka Chemika, Buchs 
Switzerland, 46960) was added and the sample was analyzed by live imaging at 0 h, 2 h and 
24 h, using an inverter Axio Observer Z1 micrsocope (Zeiss, Oberkochen, Germany, 100× 
objective). The count of the aggregates was achieved using the ImageJ software (National 
Institute for Health, Washington, DC, USA) on three images for each time point. 
2.3. Animal experiments 
BALB/c mice were used when they were between 8 and 13 weeks old. They were housed in 
the IBMC animal facility (agreement number G67-482-2). All experiments were carried out 
in conformity with the 2010/63/UE European animal bioethics legislation (French decree 
#2013-118 - 1st February 2013) and were approved by the Regional Ethics Committee of 
Strasbourg (CREMEAS) and by the French Ministry of Higher Education and Research 
(APAFIS#3280-2015121815099907 v2). 
 
2.4. Cell isolation and cell culture 
T and B lymphocytes were isolated from the spleens of BALB/c mice (8-13 weeks old) using 
the Dynabeads untouched mouse T cell isolation kit (Thermo Fisher Scientific, Illkirch, 
France, 11413D) or the Miltenyi Pan B isolation kit II (Miltenyi Biotec, Bergisch-Gladbach, 
Germany, 130-090-862), respectively. 15-20×10
6 
T cells and 20-35×10
6 
B cells were isolated 
form the spleen of a mouse. The efficiency of isolation was determined by flow cytometry by 
specific B and T cell staining with a purity nearing 95%. The cells (2.5×10
6
) were then 
stimulated with phorbol 12-myristate 13-acetate (abbreviated P, 50 ng mL
-1
, Sigma, P8139) 
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and ionomycin (abbreviated Iono or I, 1 µM, Sigma, I0634) or with purified NA/LE hamster 
anti-mouse CD3 (5 µg mL
-1
, precoated, BD Biosciences, clone 145-2C11,  553057) and 
purified NA/LE hamster anti-mouse CD28 (5 µg mL
-1
, BD Biosciences, clone 37.51, 553294) 
for T cells and lipopolysaccharide (LPS, 5 µg mL
-1
, from Escherichia coli O111:B4, Sigma, 
L2630) for B cells. FLG was added at various concentrations either immediately or 2 h after 
the different activation parameters when indicated. Cells were incubated for 24 h in a 24 well 
plate at 37°C, 5% CO2 in RPMI 1640 medium (Lonza BioWhittaker) supplemented with 10% 
FBS, 10 µg mL
-1
 gentamycin (Lonza BioWhittaker), 10 mM HEPES (Lonza BioWhittaker) 
and 0.05 mM β-mercaptoethanol (Lonza BioWhittaker).  
2.5. Flow cytometry analysis 
The cells (5×10
5
) cells were stained with the following antibodies purchased from BD 
Bioscience (Le Pont-De-Claix, France): phycoerythrin (PE)-labeled anti-mouse CD86 (clone 
GLI, 553692), Peridinin-chlorophyll proteins (PerCp)-Cyanin 5.5-labeled anti-mouse CD19 
(clone ID3, 551001), PE-labelled anti-mouse CD62L (clone MEL-14, 553151), 
allophycocyanin (APC)-labeled anti-mouse CD44 (clone IM7, 559250) and fluorescein 
isothyocyanate (FITC)-labeled annexin-V (560931). The fixable viability dye (FVD) efluor 
780 (65-0865-14), the mitochondrial superoxide indicator MitoSOX™ Red (M36008), 
MitoTracker™ Green FM (M7514) and MitoTracker Deep Red (M22426) were purchased 
from Thermo Fisher Scientific (Fisher Scientific, Pittsburgh, PA, USA,). 
2.6. Western Blot 
For western-blotting, 2×10
6
 cells were collected after 24 h incubation. When indicated 
protease inhibitors pepstatin A and E64D (5 µg mL
-1
, Sigma-Aldrich; P5318 and E8640) were 
added 4 h prior to the end of the culture. The cells were then lyzed using Laemmli buffer (125 
mM Tris-HCl, pH 6.8; 2% (w/v) sodium dodecyl sulphate (SDS); 10% (v/v) glycerol; 5% 
(v/v) β-mercaptoethanol) for total protein extraction. The proteins were separated by 
electrophoresis on a 4-20% polyacrylamide pre-cast gel (Bio-Rad, Hercules, CA, USA) 
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before being transferred on a nitrocellulose membrane (Bio-Rad), PBS supplemented with 5% 
(w/v) non-fat dry milk (Bio-Rad, ref) and 0.1% Tween-20 was used for blocking the 
membranes for 1 h. Monoclonal anti-LC3 antibodies (1 µg mL
-1
) or horse radish peroxidase 
(HRP) coupled anti-Actin β (0.1 µg mL-1, Santa Cruz Biotechnology, Heidelberg, Germany, 
clone C4, sc-47778 HRP) were incubated for 1h at room temperature (RT). For LC3 detection, 
a secondary anti-mouse IgG antibody coupled to HRP (Southern Biotech, Birmingham, AL, 
USA; 1030-05) was used. The membrane was then incubated for 2 min with the HRP 
substrates for chemiluminescence (Immobilon Western, Merck Millipore, Darmstadt, 
Germany; WBKLS0500). The resulting signal was visualized on photographic films and 
quantified by measuring the density of the bands using the ImageJ software. 
2.7. Immunofluorescence staining and acquisitions 
After 24 h incubation, ~500.000 T or B lymphocytes were transferred in a poly-L-lysine 
(Sigma-Aldrich, P8920-100ML) coated 8 chamber BD Falcon culture slide (Corning Life 
Sciences DL, Tewksbury, MA, USA, 08-774-26). After 1 h incubation at 37°C, 5% CO2, to 
favor adherence, the cells were washed in Tris-buffered saline (TBS) pH=7,4 and 
subsequently fixed in 2% (v/v) paraformaldehyde for 30 min at room-temperature (RT). Then 
the cells were washed again, before incubation in a permeabilization solution (0.05% (v/v) 
Triton, 2% v/v fetal bovine serum (FBS) in TBS, for 30 min at RT. The following primary 
antibodies were incubated with the cells over night at 4°C in TBS supplemented with 1% 
(v/v) FBS: anti-LC3 (5 µg mL
-1
, MBL, rabbit anti-mouse polyclonal antibody, NB100-2220), 
anti-Lamp2 (1 µg mL
-1
, Santa Cruz, goat anti-mouse polyclonal, sc-8100), biotinylated anti-
TCRb (2.5 µg mL
-1
, Biolegend, hamster anti-mouse IgG2, clone DO-11.10, 109204), 
biotinylated anti-I-A/I-E (2.5 µg mL
-1
, BD Pharmingen, rat anti-mouse IgG2a, clone 2G9, 
553622). After washing with TBS, the cells were incubated for 1 h at RT with the respective 
secondary stainings: an Alexa-488 coupled goat anti-rabbit antibody (2 µg mL
-1
, Molecular 
Probes A11034), a donkey anti-goat biotine antibody (Jackson, 705-065-147) and a 
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streptavidine-Alexa-546 (2 µg mL
-1
, Molecular Probes, S11225). At the same time DAPI 
(4′,6-diamidino-2-phenylindole dihydrochloride) was added to stain DNA (50 μg mL-1, 
D1306, Molecular Probes). After mounting the slides in Fluoromount-G fluorescence 
mounting medium (Thermo Fisher Scientific, 00-4958-02), they were observed under a 
confocal microscope. Pictures were acquired either on a spinning disk microscope (Zeiss 
Axio Observer Z1 with a Yokogawa CSU X1 confocal head) or on a LSM780 microscope 
(Zeiss Axio Observer Z1 with a LSM780 confocal head). The pictures shown in Figure 6 
were acquired on a LSM780 microscope (Zeiss Axio Observer Z1 with a LSM780 confocal 
head). Each fluorophore was acquired separately using 405/488/561 and 633 nm lasers to get 
their spectra. The samples stained with all fluorophores were acquired using the spectra such 
obtained and fluorophores were separated spectrally using the unmixing module of Zen 
acquisition software of Zeiss Company. The pictures in Figures S2 and S3, and the 
corresponding videos, were acquired on a spinning disk microscope (Zeiss Axio Observer Z1 
with a Yokogawa CSU X1 confocal head). The images were acquired sequentially using a 
Plan-Apochromat 100× objective NA1.4. DAPI was acquired using a 405 nm laser and a 
BP450/50 emission filter. LC3 was acquired using a 488 nm laser and a BP525/50 emission 
filter. TCRb and MHCII where acquired using a 561 nm laser and a BP629/62 emission filter. 
QD where acquired using a 488 nm laser and a BP690/50 emission filter. The z-stack shown 
in Video S1 was acquired on a Zeiss Axio Observer Z1 in widefield fluorescence microscopy 
with a Plan-Apochromat 100× objective. Pictures were acquired using the Set 44 filter cube of 
Zeiss company. The images were analyzed using the ImageJ software. 
2.8. FLG-QD preparation  
QD have been prepared as described in the literature.
22
 InCl3 (88.4 mg, 0.4 mmol) was added 
to AgNO3 (17 mg, 0.1 mmol) in a 100 mL round bottom flask. Subsequently, 190 µL of oleic 
acid (0.6 mmol), 720 µL of dodecylthiol (3 mmol) and 8 mL of octadecene were added under 
vigorous stirring (420 rpm). The dispersion was flushed with argon for 15 min. Subsequently 
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the temperature was risen and kept at 60°C for 15 min, then at 95°C for 15 min, and 110°C 
for other 15 min until dissolution of indium and silver salts. After, 9.6 mg (0.3 mmol) of S 
dissolved in 4 mL of oleylamine were rapidly added with a syringe. Immediately, the solution 
turned from pale pink to dark pink. After 15 min, 70.5 mg (0.5 mmol) of ZnCl2 dissolved in 3 
mL of oleylamine and 2 mL of 1-octadecene were added and the temperature was increased to 
150°C and kept for other 15 min. Then, the reaction was chilled with an ice bath and the 
crude compound was washed by 6 cycles of washing three times using ethanol and three 
times using acetone as anti-solvent. Finally, the QDs were dispersed in 20 mL of CH2Cl2 and 
stored at 4°C (concentration 2 mg mL
-1
). Concentration was calculated evaporating and 
weighing the solid of a known volume of solution.  
Coupling of FLG with QDs has been recently reproted by our group.
23
 Briefly, 10 µL (2 mg 
mL
-1
 CH2Cl2) of QDs were added to 100 µL (100 µg mL
-1
) aqueos dispersion of FLG. The 
biphasic solution have been sonicated at 40°C in a water bath for 10-15 min. As the organic 
phase evaporated unreacted QD have been separed via decantation, while the FLG-QD have 
been purified via centrifugation/washing several times with distilled water. 
2.9. Statistical analysis 
Based on the number of experiments and the number of conditions in each cellular test, a one-
way ANOVA Tukey test was applied in order to evaluate the statistical significance.  
 
3. Results and discussion  
3.1. FLG dispersion in cell culture media 
The main issue to overcome when working with graphene, is its poor dispersibility in 
water or in culture media. This is one of the reasons why so far, graphene oxide, was favored 
in most studies investigating the impact of graphene materials in biological systems and their 
potential use in biomedical applications
24
. However, in the last years, several exfoliation 
methods, aiming to overcome this difficulty, have been developed. The FLG used for this 
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study was obtained by mechanochemical exfoliation using a ball milling technique in the 
presence of melamine as the exfoliating agent. Briefly, a mixture of graphite and melamine 
was ball milled at 100 rpm for 30 min under air. The resulting solid mixture was dispersed in 
water and briefly sonicated to produce a dark suspension. Melamine was then eliminated by 
dialysis. Some precipitate, consisting in poorly exfoliated graphite, was removed from the 
liquid fraction after stabilization for 5 days.
20,21
  The final FLG water dispersions were 
lyophilized and the final graphene powder was thoroughly characterized (Figure S1). The 
advantage of this graphene lies in the fact that it can be lyophilized and then easily 
resuspended in culture media. Transmission electron microscopy (TEM) analysis revealed a 
lateral size distribution of FLG ranging from 100 nm to 1600 nm (Figure S1A).  Raman 
average spectrum of FLG is composed by the typical graphene Raman bands: G peak, D peak 
and 2D band, which are centered at ~ 1580 cm
-1
, ~ 1350 cm
-1
 and ~ 2680 cm
-1
, respectively 
(Figure S1C). A ID/IG ratio of 0.28 and the full-width at half maximum (FWHM) of 2D band 
of 65.54 cm
-1
 confirmed the few layer nature of the graphene sample.
20
 The elemental 
analysis of FLG showed that the sample is mostly composed of carbon (Figure S1D), and the 
melamine traces resulted in maximum 0.93 ppm, as calulated from the powder dispersion at 
0.1 mg mL
-1
. We further investigated the amount and size of the possible aggregates formed 
in the culture medium over time by confocal microscopy, in order to study in a deeper way 
the material availability for the cells. By exploiting a property of graphene, namely its 
capacity to quench fluorescence, we resuspended the lyophilized FLG at a concentration of 
100 µg mL
-1
 in fetal bovine serum (FBS) supplemented RPMI culture medium, in the 
presence of fluorescein. For this set of experiments, we used a 2 mL test vial capped with a 
cover slip on the bottom and filled with one ml of 0.1 mg mL
-1
 FLG dispersion. The images, 
taken on a widefield microscope at three different time points, were recorded in proximity to 
the cover slip where sedimentation would occur. As expected, due to the sedimentation 
process, the number of FLG aggregates visible in the vial bottom increased during time 
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(Figure 1A). Lateral size of the agglomerates was measured using the ImageJ software and 
analyzed as reported in Figure 1B and 1C. At the beginning, the sediment is composed by 
31% of aggregates with lateral size ≥ 7 µm meanwile the composition of small aggregates of 
5, 3 and 1 µm is 15, 23 and 31%, respectively. After two hours, the contribution of large big 
agglomerates is reduced to 20% while more than half of the population (51%) is composed by 
small aggregates (≤ 1 µm). After 24 h, the sediment was composed in majority of small 
agglomerates (≤ 1 µm 58%) while the contribution of larger aggregates (> 7 µm) is reduced to 
6%. This latter tendency can be explained considering that the sedimentation velocity is 
strictly dependent on the particle size. For this reason, at the beginning the sediment is 
composed by a more prominent part of large aggregates. Subsequently FLG sheets in 
suspension tend to interact forming small aggregates that slowly precipitate.  However, the 
movie obtained from different focal planes on the widefield microscope (See Supplementary 
Video S1) after 24 h confirmed that most of the small FLG aggregates are still in suspension. 
We would like to underline that the individual FLG nanosheets cannot be visualized by this 
technique. Besides, the observed micro-flakes can be deposited closely to or attached on the 
cell membrane and so they could induce direct stimulations to the cells through the physical 
contact.
25
 Overall, this analysis was necessary to estimate the availability of FLG to the cells 
during the incubation. It appears indeed that at early time points, the material is mostly in 
suspension and can interact with cells that are also in suspension, as it is the case of the 
lymphocytes studied here.  
3.2. Impact of FLG on lymphocyte viability and activation 
The first step to understand the impact of FLG on lymphocyte function, was to evaluate 
its influence on their viability and activation. For this purpose, we incubated B or T 
lymphocytes isolated from spleens of BALB/c mice, for 24 h with a low (10 µg mL
-1
) and a 
high (100 µg mL
-1
) concentration of FLG alone or with FLG after pre-activating the cells, 
using either phorbol 12- myristate 13-acetate and ionomycin (P/I) or anti-CD3 and anti CD28 
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agonist antibodies for T cells and lipopolysaccheride (LPS) for B cells. Initially, we 
performed a dose response analysis using concentrations of 1, 10, 25, 50 and 100 µg mL
-1
. As 
the results did not show any significant effect in the cellular tests, except on B cell activation 
at 100 µg mL
-1 
(data not shown), we considered the latter as the highest dose. However, to 
ensure that we did not miss events that might occur at low concentrations, we also used a dose 
10 times lower in all experiments. The viability was assessed by flow cytometry using the 
fixable viability dye (FVD) and annexin V. FVD is  a dye that crosses the membranes of dead 
cells and react with free amines in the cytoplasm, while annexin V detects apoptotic cells by 
binding phosphatidylserines. The gating strategy is shown in Figure 2A. FVD and annexin V 
negative subsets represent the percentage of live cells. As evidenced by these results, FLG 
seems to have no specific impact on the viability of the lymphocytes as the percentages of live 
cells remain about 60% with or without FLG (Figure 2B and 2C). The pre-activation 
improves the viability mainly in B lymphocytes without however being hampered neither by 
the low nor the high concentration of FLG. We then wanted to see whether FLG could play a 
role in the activation of these cells by measuring the expression of activation markers such as 
CD62L and CD44 for T cells and CD86 for B cells, respectively (Figure 2D). We did not see 
any difference in T lymphocyte activation even when the cells were pre-activated 
pharmacologically (P/I) or with agonist antibodies (anti-CD3/CD28) (Figure 2E). These 
results are in agreement with the study by Russier et al. in which the authors evaluated the 
impact of FLG on human peripheral blood mononuclear cells. In fact their screening on 
different human immune cell populations did not reveal any FLG mediated toxicity nor 
activation of T cells.
19
 Similar observations were made on natural killer cells, on dendritic 
cells and on B cells. The observed effect was strictly restricted to monocytes. In the present 
study however, we noticed a dose dependent increase of the expression of the activation 
marker CD86 in the presence of graphene on B cells, with an increase of ~9% between the 
untreated condition and the low dose FLG and of ~20% with the high dose. With the P/I or 
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LPS stimulation, these differences were abolished (Figure 2F), potentially suggesting that at 
this time point we have reached the maximum activation threshold that cannot be further 
boosted, even in presence of FLG. Often in the literature we can see differences when various 
graphene materials are investigated, but in our conditions the material used was the same. 
Thus, the discrepancies with Russier et al. could be due to differences in the species (human 
vs mouse) but more likely to differences in the immunological compartments of interest in the 
two studies (peripheral blood vs spleen). Even though cross-species comparisons have been 
shown to vary between mouse and human, those are mainly at the developmental rather than 
the activation level.
19
 However, in terms of B cell subsets, they can change depending on the 
compartments studied, with a higher proportion of mature B cells and some transitional 1 (T1) 
B cells in the periphery, while the spleen is populated by mature, T1 and T2 B cell subsets. In 
this context, we studied the effect of FLG on isolated B cells rather than on total PBMCs, 
composed of many different immune cells. Thus another hypothesis could be that we have a 
cumulative effect that might have passed unnoticed in a heterogenous immune cell population.  
3.3. Study of lymphocyte autophagic function in the presence of FLG 
Analyzing the results on cell viability and activation, we hypothesized that other 
mechanisms essential for lymphocyte homeostasis could be affected by FLG. As mentioned 
previously, autophagy is a major player in lymphocyte function. Thus, we decided to 
investigate if this process could potentially be modulated by graphene as well. For this 
purpose, we used the Western-blot technique for the detection of the membrane bound LC3-II 
protein, resulting from the conjugation of its cytosolic form LC3-I to phosphatidyl-
ethanolamine. This protein is commonly used as an autophagic marker because of its 
association to the autophagic compartments throughout the entire process. As these 
compartments possess a double membrane, the LC3-II protein present in the inner membrane 
will be degraded once the autophagosomes fuse with the lysosomes. The use of protease 
inhibitors abolishes this part of the process and allows to visualize the total LC3-II mobilized 
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proteins, but also to estimate the rate of autophagic turnover by comparing the conditions with 
and without protease inhibitors (Figure 3A and 3D). Using the same parameters of incubation 
time and activation described above, we quantified the LC3-II protein by measuring the 
density of the bands relative to -Actin, serving as the protein loading control (Figure 3B and 
3E). As expected we had a high accumulation of autophagic membranes in physiologically 
and pharmacologically activated conditions both in T (antiCD3/CD28 or P/I) and B cells 
(LPS or P/I) in comparison to the untreated cells. However, we did not see variations when 
comparing with conditions incubated with graphene. Also, the evaluation of the autophagic 
flux did not evidence statistically significant differences (Figure 3C and 3F). Thus, it seems 
that FLG has no major impact on this cellular process. Autophagy was shown to be a complex 
and fine-tuned process in lymphocytes. In B cells the importance of this mechanism appears 
to vary depending on their stage of differentiation and the immunological compartment they 
are localized in, but autophagy is mostly required for the survival of long-lived antibody-
secreting B derived plasma cells.
26,27
 In the case of T cells, autophagy is essential for the 
formation of memory CD8+ T cells, while for memory CD4+ T cells, it is required for their 
survival. Overall, it is rather reassuring that FLG does neither decrease nor increase 
autophagy. This is in contrast with other GBMs such as carbon nanotubes or GO, that have 
been shown to rather block the autophagic flux in RAW macrophages and peritoneal 
macrophages, respectively.
15,27
 A very recent study, demonstrated that FLG at low doses 
could trigger autophagy in an ER-stress dependent manner and act as a protective mechanism 
in macrophages.
28
 In our case, it is the first time that the impact of FLG on autophagy is 
focused on the major players of the adaptive immune response and as such, it could be 
interesting to study its impact on memory immune responses as well. Indeed, in in vivo 
settings, it is possible that this material might remain for longer times in the body, possibly 
triggering a response that could also impact autophagic functions. In an in vivo study by 
Sasidharan et al., it was observed in fact, the presence of pristine and functionalized graphene 
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aggregates in some organs (lung, liver, and spleen) of mice, up to 90 days post-injection of 
the material.
29
 
3.4. Evaluation of intracellular stress in lymphocytes incubated with FLG 
Despite the fact that we noticed no particular changes in the autophagic turnover, we 
could not rule out the possibility of early signs of cellular stress. For this purpose, we 
evaluated the mitochondria load in the lymphocytes, their functional state (Figure 4), and the 
production of ROS (Figure 5). By incubating the cells with two dyes, mitotracker green (MT-
Green) and mitotracker deep red (MT-DeepRed) and using flow cytometry, we were able to 
distinguish three cell populations (Figure 4A). Since MT-Green stains all mitochondrial 
membranes, it allows to evaluate the mitochondrial load, while MT-DeepRed, being sensitive 
to mitochondrial potential, is useful to establish the respiratory status of these organelles. As 
in all our experiments the lymphocytes were incubated for 24 h in the indicated conditions 
(Figure 4B). We observed as expected different distributions of the three populations 
depending on the cell type, reflecting the differences in metabolism between T and B 
lymphocytes. In both we saw an increased percentage of cells with a high mitochondrial 
content (MT-Green high and MT-DeepRed high) associated with a decrease in cells with 
damaged mitochondria (MT-Green high and MT-DeepRed low) when the lymphocytes were 
activated (Figure 4A). The presence of FLG, in the activated conditions, did not significantly 
alter these parameters even though it appeared a slight increase of damaged mitochondria in 
LPS activated B cells in the presence of the highest concentration of FLG (100 µg mL
-1
, 
Figure 4B). A minor diminution in T and B cells with a high mitochondria load, when 
incubated with 100 µg/mL FLG alone, is also observable. The assessment of ROS production 
was also done by flowcytometry. We used MitoSOX to detect the production of superoxide, 
the major mitochondrial ROS (Figure 5A). In T lymphocytes, superoxide was in average 
higher than in B cells, but the presence of graphene did not remarkably alter the generation of 
superoxide (Figure 5B). In B lymphocytes, however, we could measure a small increase of 
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ROS in the conditions incubated with 100 µg mL
-1
 FLG. The overall conclusion to these 
observations is that at 24 h there are no significant metabolic variations as demonstrated in 
mitochondrial load and function. On the other hand, we cannot completely rule out that at 
longer incubation times, this would not change as some results point out signs of cellular 
stress, which could potentially have an impact on autophagic functions as well.  In fact, a 
comparative study between FLG and GO impact on metabolic function of a keratinocyte cell 
line, led to the conclusion that FLG is able to induce a significant increase in ROS production 
after 7 days of incubation with the material.
30
  
3.5. Study of the interaction of FLG with the lymphocyte cell membranes and 
autophagic compartments  
In addition to the previous observations, we wanted to better understand the nature of the 
interaction of FLG with the lymphocytes. This could indeed be evaluated by 
immunofluorescence using confocal microscopy. In order to visualize the FLG, we 
functionalized this material with quantum dots (QD). After analysis of the images we noticed 
that the FLG-QD (pink) were in close vicinity to the B cell membrane (MHC-II staining, red) 
but also the T cell membrane (TCRb staining, red) (Figure 6A and 6B). The FLG was also 
observed by transmission as black spots that overlap with the pink staining (see Trans-Merge 
panels). However, we did not see any co-localization with the membranes. Even though we 
did not study the nature of this interaction in detail, we can hypothesize that it does not induce 
membrane damages, since we could neither observe them by carefully analyzing the Z-
stacking of the confocal images (see Supplementary Figure S2 and S3 and Video S2 and S3), 
nor did we see any specific toxicity effect, as demonstrated in previous experiments (Figure 
2-5). Nevertheless, this does not exclude a lipid-graphene interaction. Indeed, graphene sheets 
have been shown to interact with membrane lipids in various manners, leading possibly to 
lipid extraction, which appears to be influenced by the polarity and curvature of the 
material.
31,32
 This aspect requires further investigation in order to understand exactly how 
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FLG interacts with the lymphocyte membrane and if this proximity is indeed entirely 
harmless. But given our results on viability, autophagic activity and oxidative stress, so far 
there is no indication that the physical interaction with the lymphocytes membranes induces 
any damage. 
 We were also interested in investigating whether the FLG could be seen interacting or 
even inside the autophagic membranes. For this purpose, we did a LC3 staining (green) 
(Figure 6A and 6B). As LC3 proteins are both cytosolic (LC3-I) as well as membrane-bound 
(LC3-II), the presence of autophagosomes is demonstrated by the formation of dots. Judging 
from the confocal images and their 3D reconstruction, we saw neither the presence of FLG 
inside the cells nor in co-localization with the LC3 dots (see Supplementary Figure S2 and S3 
and Video S2 and S3). These observations were mostly qualitative and not quantifiable per se, 
but they can explain why we did not see any difference when quantifying the autophagic 
activity by Western blot (Figure 3). It is also important to mention that these cells have a very 
small cytoplasm, which could limit the penetration of the material and confer a certain 
protection. So far, most observations have been focusing on macrophages and in these cells 
FLG could be easily seen in their cytoplasm, associated to an increased autophagic activity 
and oxidative stress.
28
 This seems to indicate that FLG influences mostly cellular functions of 
phagocytic cells while the lymphocytes are spared. 
 
4. Conclusion 
This study has allowed us to reach a better understanding of primary lymphocyte function 
in the presence of few layer graphene. By using FLG that can be easily dispersed in cell 
culture media, we were able to show that this material does not lead to significant death of the 
lymphocytes. Even though it appears to exert some activation effects in B cells, these effects 
seem mild and they do not occur in T cells. We also analyzed the general autophagic activity, 
which is important to maintain normal cellular functions, but we did not see again any 
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changes. This is also in agreement with the observations, made by confocal microscopy, 
showing an interaction with the cell membrane whereas no material was visualized inside the 
cells. On the other hand, we could not increase the FLG concentration above 100 µg/mL since 
we had to take into account the limit in dispersibility of the material. Too high concentrations 
would have led to the formation of big aggregates that would have not been internalized by 
lymphocytes that are small non-phagocytic cells. 
Considering all our data, FLG appears to be overall safe on the lymphocytes, which is a 
first step in favor of in vivo studies. In this case, it would be of great interest to further 
investigate the impact of FLG on lymphocyte autophagy and function on the long-term but 
also its influence on the interaction of lymphocytes with other immune cells in order to have a 
throrough overview of the impact of our material on immune basic functions. A follow-up of 
this work in tumor models might also allow us to better link the data obtained in this study to 
the results from Russier et al. and explain the observed discrepancies in terms of B cell 
activation and if this difference can be observed in in vivo settings. However, the specificity 
of FLG to induce cell death in monocytes while spearing other immune cells and the mild 
impact seen on lymphocytes in our conditions, are in favor of further pursuing the studies on 
FLG in biological systems. FLG may indeed be an interesting tool to be used in the future, in 
combined therapies to treat cancers such as acute myeloid leukaemia or even other monocyte 
associated disorders. Thus, investigating the safety of this material and its impact on different 
cells and cell functions such as autophagy is a key step towards this goal.  
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Figure 1: Study of FLG aggregates dispersion in culture media. A) Representative confocal 
images taken at 0 h, 2 h and 24 h after the dispersion of FLG in FBS supplemented RPMI 
medium at 0.1 mg mL
-1 
and in presence of fluorescein (in green). The white arrows indicate 
the FLG aggregates at the bottom of the vial. The observations were made with a 100× 
objective and the indicated scale is of 20 µm. B) Graph representing the size distribution of 
the FLG aggregates measured from the confocal images at the bottom of the vial at 0 h, 2 h 
and 24 h. C) Graph representing the aggregates counted according to their size and the size 
distribution in % according to the total number of aggregates counted for each time point. 
Three images per time point were taken for measuring and counting the aggregates. 
**p<0.007; ****p<0.00005 (One-way ANOVA, Tukey test). 
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Figure 2: Impact of FLG on lymphocyte function. A) Representative flow cytometry dot 
plots illustrating the viability staining of T and B lymphocytes with FVD and Annexin V after 
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24 h incubation. The two left panels show the staining of the cells that were not treated (NT) 
and the right panels the cells that were incubated with FLG at a concentration of 100 µg mL
-1
. 
B) Relative percentages of T lymphocytes with a negative staining for annexin V (AV-) and 
FVD (FVD-) after 24 h incubation in the indicated conditions. Each point represents an 
independent experiment. (P/I= phorbol 12- myristate 13-acetate and ionomycin, CD3/CD28 = 
anti-CD3+anti-CD28, FLG100 = 100 µg mL
-1
 FLG). C) Relative percentages of B 
lymphocytes with a negative staining for Annexin V (AV-) and FVD (FVD-) after 24 h 
incubation in the indicated conditions. Each point represents an independent experiment. 
(LPS= lipopolysaccharide). D) Representative flow cytometry dot plots showing the 
expression of T (top) and B cell (bottom) activation markers CD62L/CD44 and CD86 
respectively, after 24 h activation. E) Relative percentages of activated (=CD44+) T cells for 
the indicated conditions after 24 h incubation. F) Relative percentages of activated (=CD86+) 
B cells for the indicated conditions after 24 h incubation. n=3-5, *P< 0.05; **P <0.01 (One-
way ANOVA, Tukey test). 
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Figure 3: Evaluation of FLG capacity to modulate the autophagic activity in lymphocytes. A) 
Representative Western-blots of the LC3 proteins in T cells incubated for 24 h with the 
indicated conditions and treated 4 h prior the end of the culture with protease inhibitors 
[E64D/pepstatin A (pepA)]. Expression of -Actin was used as an internal protein loading 
control. B) Relative quantification of the density of LC3-II normalized to -Actin (ratio LC3-
II/-ActP/Iin) and to the condition P/I (+). C) Evaluation of the autophagic flux by 
representing the ratio between the conditions with (+) and without (+) E64D/pepA, n=3-4. D) 
Representative Western-blots of the LC3 proteins in B cells incubated for 24 h with the 
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indicated conditions and treated 4 h prior the end of the culture with protease inhibitors E64D 
and pepA. Expression of b-Actin was used as an internal protein loading control. E) Relative 
quantification of the density of LC3-II normalized to b-Actin (ratio LC3-II/-Actin) and to 
the condition P/I (+). F) Evaluation of the autophagic flux by representing the ratio between 
the conditions with (+) and without (+) E64D/pepA, n=3. P>0.05 (One-way ANOVA, Tukey 
test) 
 
 
 
 
 
 
Figure 4: Impact of graphene-lymphocyte interaction on mitochondrial load. A) 
Representative flow cytometry dot plots of T and B lymphocytes after MitoTracker deep red 
(MT-DeepRed) and MitoTracker green (MT-Green) staining. Three cell populations can be 
distinguished: cells with a high mitochondrial content (HIGH MT), cells with damaged 
mitochondria (DAM MT) and cells with a low mitochondrial content (LOW MT). B) Relative 
percentages of the mitochondrial content in T and B lymphocytes in the indicated conditions, 
n=4. P>0.05 (One-way ANOVA, Tukey test) 
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Figure 5: Modulation of ROS production in B and T cells in the presence of FLG. A) 
Representative flow cytometry dot plots of T and B lymphocytes after incubation with the 
superoxide marker (MitoSOX) and the fixable viability dye (FVD). B) Relative percentages 
of MitoSOX positive live T and B lymphocytes for the indicated conditions, n=4. P>0.05 
(One-way ANOVA, Tukey test) 
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Figure 6: Study of the interaction of FLG with lymphocyte membranes and autophagic 
compartments. A) Representative confocal images of B lymphocytes after 24 h incubation 
with 10 µg mL
-1 
FLG-QD. The nucleus is stained with DAPI (blue), the autophagosomes with 
an anti-LC3 antibody (green) and the membranes with an anti-MHC-II antibody (red). The 
three staining are shown in a merged image with and without the transmission. B) 
Representative confocal images of T lymphocytes after 24 h incubation with 10 µg mL
-1
 
FLG-QD (pink). The nucleus is stained with DAPI (blue), the autophagosomes with an anti-
LC3 antibody (green) and the membranes with an anti-TCRb antibody (red). The three 
staining are shown in a merged image with and without the transmission image. 
